A whole-economy model of the health co-benefits of strategies to reduce greenhouse gas emissions in the UK

A whole-economy model of the health co-benefits of strategies to reduce greenhouse gas emissions in the UK

Meeting Abstracts A whole-economy model of the health co-benefits of strategies to reduce greenhouse gas emissions in the UK Marcus Keogh-Brown, Henni...

60KB Sizes 0 Downloads 38 Views

Meeting Abstracts

A whole-economy model of the health co-benefits of strategies to reduce greenhouse gas emissions in the UK Marcus Keogh-Brown, Henning Tarp Jensen, Richard D Smith, Zaid Chalabi, Mike Davies, Alan Dangour, Phil Edwards, Tara Garnett, Moshe Givoni, Ulla Griffiths, Ian Hamilton, James Jarrett, Ian Roberts, Paul Wilkinson, James Woodcock, Andy Haines

Abstract Published Online November 23, 2012 For all Public Health Abstracts see http://www.thelancet.com/ abstracts/public-health-sciencein-the-uk Faculty of Public Health and Policy (M Keogh-Brown PhD, Prof R D Smith PhD, Z Chalabi PhD, U Griffiths PhD, Prof P Wilkinson FRCP, Prof A Haines FMedSci) and Faculty of Epidemiology and Population Health (A Dangour PhD, P Edwards PhD, Prof I Roberts FRCP), London School of Hygiene and Tropical Medicine, London, UK; Institute of Food and Resource Economics, University of Copenhagen, Copenhagen, Denmark (H Tarp Jensen PhD); The Bartlett School of Graduate Studies, University College London, London, UK (Prof M Davies PhD, I Hamilton MSc); Food Climate Research Network, University of Surrey, Guildford, UK (T Garnett MA); School of Geography and the Environment, Oxford University, Oxford, UK (M Givoni PhD); Norwich Medical School, Health Economics Group, University of East Anglia, Norwich, UK (J Jarrett PhD); and UKCRC Centre for Diet and Activity Research (CEDAR), Institute of Public Health, University of Cambridge, Cambridge, UK (J Woodcock PhD) Correspondence to: Dr Marcus Keogh-Brown, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London WC1H 9SH, UK marcus.keogh-brown@lshtm. ac.uk

Background The UK Government has set specific targets for greenhouse gas emissions to lower the risk of dangerous climate change. Previous research has shown that important health co-benefits could result from strategies targeting the domains of transport, built environment, and agriculture. This study assesses the full general equilibrium economy-wide macroeconomic effects of health co-benefits from three similar UK strategies to meet locally specific 2030 greenhouse gas emission targets. Methods Economy-wide effects of health co-benefits were modelled with a dynamic extension of the widely used International Food Policy Research Institute standard computable general equilibrium model for 2011–30. Four forms of economic agents are modelled: firms (who combine resource inputs to maximise profits), consumers (who consume and save to maximise their welfare), government, and foreign agents. The method consists of simulation of three greenhouse gas policy scenarios and a counterfactual do-nothing scenario. Basic health co-benefits (years lived with disability [YLD] and years of life lost [YLL]) were measured for a range of illnesses, on the basis of the comparative risk assessment approach. Combined with incidence numbers and prevalence trends, these basic YLD (morbidity) and YLL (mortality) co-benefits were used to calculate dynamic sequences of demographic and labour market effects on population and productive labour supply, and public budget implications for averted health-care costs and increased social security transfers (including benefit payments for working-age individuals and pension payments for old-age individuals). These economic shocks were subsequently imposed on the computable general equilibrium model and used to measure the combined macroeconomic effect of health co-benefits. The method for measuring averted health-care costs was published in The Lancet in 2012. Three scenarios were modelled: active travel (transport sector; health co-benefits of an assumed transformation of urban transport behaviour to reduce motorised transportation and increase walking [2·5-times] and cycling [8·0-times] in urban England and Wales); healthy diet (food and agriculture sector; health co-benefits of an assumed UK-wide 30% reduction in consumption of dietary saturated fat); and household energy (household energy sector; health co-benefits of an assumed UK-wide improvement in home insulation and ventilation, including reduced household energy use, improved indoor temperature, and associated changes in indoor pollutants). Findings For all scenarios, the macroeconomic effects of health co-benefits are positive. Overall, substantial savings on health-care costs represent the main contributing factor. Increased labour supplies also contribute positively, whereas increased social security transfers (due to larger working-age and old-age population segments) detract. The largest potential cumulative gross domestic product gains from health co-benefits are associated with the active travel scenario (around £19 billion), in which increased physical activity averts large-scale and long-term chronic disease burdens and health-system costs. The healthy diet scenario also leads to important potential gains (around £5 billion), whereas the full potential health co-benefits from the household energy scenario will not be realised until beyond 2030. Three economic sensitivity analyses were undertaken to test the sensitivity of results to variations in assumptions concerning: the substitutability of labour for other factors of production; the effectiveness of the interventions; and changes in the discount rate (the present value of the economic effects). Overall, the core results can be considered relatively robust to changes in these three factors. Interpretation Strategies to reduce greenhouse gas emissions and improve health are likely to result in substantial and increasing positive contributions to the economy. This effect might offset some economic costs and thereby allow such strategies to be seen more favourably, especially in times of economic austerity. Funding Department of Health Policy Research Programme. Contributors RDS, MK-B, HTJ led the conceptual development of the paper. AD, PE, TG, MG, UG, JJ, IH, IR, PW, and JW provided advice on scenarios and data inputs. ZC contributed to the health impact analysis. RDS supervised, MK-B conducted, and HTJ advised on the CGE modelling. RDS lead the drafting of the paper. AH led the development of the research protocol for funding the work. All authors contributed to the intellectual guidance, analysis, and subsequent drafts of the paper. MKB and HTJ are the guarantors for the study. Conflicts of interest We declare that we have no conflicts of interest.

52

www.thelancet.com